Rastetter William H's Form 4 filing
Neurocrine Biosciences Inc (NBIX) · filed Aug 16, 2024
- Accession no.
- 0000914475-24-000197
- Filed
- Aug 16, 2024
- Trade date
- Aug 15, 2024
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Not checked
This filing lists 1 non-derivative transaction. Open-market sales total $2.09M. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Rastetter William HCIK 0001205903 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 15, 2024 | Common Stock | SSaleDisposed | −14,250 | $146.69F1 | −$2,090,332.5 | 37,491 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
The Reporting Person contributed Issuer common stock to an exchange fund for shares of the exchange fund. The Issuer common stock was valued at $146.69 per share for the purpose of determining the number of shares of the exchange fund issuable to the Reporting Person.
Referenced by the price of 1 transaction in Table I.